Skip to main content
Caplight Logo









Spearhead Bio

Spearhead Bio

Private
St. Louis, MissouriHealthcare & Life Scienceshttps://danforthtechnology.com/

Last Round

Seed Round

Jun 23, 2026

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Spearhead Bio is an agricultural biotechnology company that leads the next generation of native genome engineering tools to accelerate the development and launch of new transgenic & non-transgenic crops.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

genome engineeringTAHITIgene insertionagricultural biotechnologycrop improvementag-techgene editingTransposase Assisted Homology Independent Targeted Insertioncrop breedingtransposase technologyCRISPR complementplant sciencetrait stackingtransgenic cropsnon-transgenic crops

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Spearhead Bio Comparables

Compare Spearhead Bio with similar companies based on industry and business-model similarity.

Spearhead Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Solis Agrosciences
83%
Demeetra AgBio
78%
Hudson River Biotechnology
76%

Spearhead Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundJun 23, 2026
VC RoundJan 29, 2026
GrantJul 14, 2025
SeedMay 13, 2025

Key People

Founding team and executive leadership

Tom Laurita

Chief Executive Officer

Executive Team

Spearhead Bio Investors

Notable investors and investment history

Spearhead Bio investors
InvestorRounds
Danforth Technology CompanyVC Round, Seed
BioGenerator VenturesVC Round, Seed
Helix FundSeed
National Science FoundationVC Round, Grant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 23, 2026

    $1.2M raised in Seed Round.

  • Jan 29, 2026

    $4M raised from BioGenerator Ventures and others.

Spearhead Bio Filings

Explore SEC and related filing metadata, where available.

Spearhead Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Spearhead Bio's valuation, stock price, and market status.

Is Spearhead Bio a public or private company?

Spearhead Bio is a private company.

What is the current stock price of Spearhead Bio?

Spearhead Bio is a private company with no public stock price. No recent secondary market data is available.

How much is Spearhead Bio worth (valuation)?

Valuation information for Spearhead Bio is not publicly available.

Can I buy Spearhead Bio stock?

Spearhead Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Spearhead Bio's last funding round?

Spearhead Bio's most recent funding round was Seed Round on June 23, 2026.

Who are the main investors in Spearhead Bio?

Key investors in Spearhead Bio include Danforth Technology Company.

Will Spearhead Bio IPO soon?

No public IPO plans have been announced for Spearhead Bio.

How can I track Spearhead Bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Spearhead Bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSt. Louis, Missouri
Employee Range2
Year Founded2025
Last FundingJun 23, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?